tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALPMF Stock Latest News

Astellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
RatingsAstellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
5d ago
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Potential Game-Changer?
23d ago
PFE
Pfizer and Astellas Pharma’s Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Pfizer and Astellas Pharma’s Prostate Cancer Study: A Potential Game-Changer?
25d ago
PFE
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
PremiumCompany Announcements
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
26d ago
Astellas Pharma’s ASP3082 Study: A New Hope for KRAS G12D Mutation in Cancer
PremiumCompany Announcements
Astellas Pharma’s ASP3082 Study: A New Hope for KRAS G12D Mutation in Cancer
1M ago
Astellas Pharma’s Phase 3 Study on Fezolinetant: A Potential Game-Changer for Menopausal Hot Flashes
PremiumCompany AnnouncementsAstellas Pharma’s Phase 3 Study on Fezolinetant: A Potential Game-Changer for Menopausal Hot Flashes
1M ago
Astellas Pharma’s ASP3082 Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Astellas Pharma’s ASP3082 Study: A Potential Game-Changer in Cancer Treatment
1M ago
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopause Treatment
Premium
Company Announcements
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopause Treatment
1M ago
Astellas Pharma Advances AMD Treatment with New ASP3021 Study
PremiumCompany Announcements
Astellas Pharma Advances AMD Treatment with New ASP3021 Study
1M ago
Astellas Pharma’s Promising AML Study: A Potential Game Changer?
PremiumCompany Announcements
Astellas Pharma’s Promising AML Study: A Potential Game Changer?
1M ago
Pfizer and Astellas Advance Prostate Cancer Study with Promising Drug Combo
PremiumCompany Announcements
Pfizer and Astellas Advance Prostate Cancer Study with Promising Drug Combo
1M ago
PFE
Pfizer and Astellas Pharma’s Promising mCRPC Study Update
PremiumCompany Announcements
Pfizer and Astellas Pharma’s Promising mCRPC Study Update
1M ago
PFE
Astellas Pharma Completes Key Study on Roxadustat for Renal Anemia
PremiumCompany AnnouncementsAstellas Pharma Completes Key Study on Roxadustat for Renal Anemia
1M ago
Astellas Pharma’s New Study on ASP3021: A Potential Game-Changer for AMD Treatment
Premium
Company Announcements
Astellas Pharma’s New Study on ASP3021: A Potential Game-Changer for AMD Treatment
1M ago
Astellas Pharma’s Peficitinib Study: Real-World Insights into Rheumatoid Arthritis Treatment
Premium
Company Announcements
Astellas Pharma’s Peficitinib Study: Real-World Insights into Rheumatoid Arthritis Treatment
2M ago
Astellas Pharma’s ASP3021 Study: A Potential Game-Changer in AMD Treatment
PremiumCompany Announcements
Astellas Pharma’s ASP3021 Study: A Potential Game-Changer in AMD Treatment
2M ago
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: Market Implications
PremiumCompany Announcements
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: Market Implications
2M ago
PFE
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
PremiumCompany Announcements
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
2M ago
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Market Game-Changer?
PremiumCompany Announcements
Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Market Game-Changer?
2M ago
PFE
Astellas Pharma’s ASP3082 Study: A New Hope for Advanced Solid Tumors
PremiumCompany AnnouncementsAstellas Pharma’s ASP3082 Study: A New Hope for Advanced Solid Tumors
2M ago
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopause Treatment
Premium
Company Announcements
Astellas Pharma’s Fezolinetant Study: A Potential Game-Changer for Menopause Treatment
2M ago
Astellas Pharma’s ASP0367 Study Terminated: Implications for Investors
Premium
Company Announcements
Astellas Pharma’s ASP0367 Study Terminated: Implications for Investors
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >